Skip to main content
. 2022 Mar 2;1:100023. doi: 10.1016/j.focha.2022.100023

Fig. 1.

Fig 1

Schematic diagram representing potential candidates originating from mushrooms, such as polysaccharides, lectins, terpenes, polyphenols, and lipids, can be investigated for possession of high degree antiviral, anti-inflammatory and immunomodulatory effects for prevention and therapy of SARS-CoV-2.